Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -245.84%-3.64M | -237.74%-2.12M | 12.21%-1.49M | 32.39%-4.7M | 16.35%-1.32M | 39.28%-1.05M | 69.98%-628.29K | -10.00%-1.69M | -126.72%-6.95M | 31.51%-1.58M |
| Net income from continuing operations | -776.69%-9.02M | -14.83%-1.95M | 1.22%-1.81M | 60.55%-6.08M | 49.66%-1.52M | 59.69%-1.03M | 40.50%-1.7M | 73.74%-1.83M | 17.86%-15.4M | 82.63%-3.02M |
| Operating gains losses | -92.25%2.32K | -85.74%-6.11K | -107.32%-108 | 76.63%30.89K | --2.8K | --29.9K | ---3.29K | --1.48K | 495.52%17.49K | ---- |
| Depreciation and amortization | -97.76%602 | -98.55%401 | --0 | -23.23%86.88K | 101.29%4.36K | -88.28%26.92K | -75.06%27.63K | -74.91%27.97K | 25.32%113.16K | -0.24%-338.79K |
| Asset impairment expenditure | ---- | ---- | ---- | --327.78K | ---- | ---- | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | 1,488.58%4.51M | 180.59%538.23K | 1,141.72%607.01K | -99.97%1.06K | -84.75%191.99K | -142.96%-324.48K | -88.18%191.82K | -120.62%-58.27K | 520.16%3.92M | 99.18%1.26M |
| Other non cashItems | ---- | ---- | ---- | -98.98%51.88K | 39.49%36.28K | -66.37%12.76K | 103.78%1.99K | -99.98%855 | -64.38%5.07M | --26.01K |
| Change In working capital | 277.77%877.61K | -183.41%-707.9K | -263.89%-279.95K | 232.87%882.67K | -178.81%-369.2K | 214.98%232.31K | 191.76%848.74K | 3,057.36%170.82K | -190.38%-664.32K | -10.90%468.45K |
| -Change in receivables | -221.15%-33.61K | 246.27%60K | 52.13%-30.91K | -934.95%-102.54K | -524.02%-24.68K | 173.63%27.74K | -27.58%-41.02K | -175.04%-64.58K | 111.42%12.28K | -112.30%-3.96K |
| -Change in prepaid assets | -236.94%-94.42K | -156.87%-40.91K | -111.37%-136.2K | 168.53%144.17K | -64.86%67.72K | -63.49%68.95K | 113.70%71.95K | 3.32%-64.44K | -790.32%-210.38K | 5,329.82%192.72K |
| -Change in payables and accrued expense | 3,714.25%1.01M | -282.94%-661.49K | -54.25%137.17K | 212.72%525.54K | -158.01%-162.24K | 107.46%26.37K | 198.39%361.58K | 1,290.58%299.84K | -153.82%-466.22K | -43.76%279.68K |
| -Change in other working capital | --0 | ---65.5K | ---250K | --315.5K | ---250K | --109.26K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -245.84%-3.64M | -237.74%-2.12M | 12.21%-1.49M | 32.39%-4.7M | 16.35%-1.32M | 39.28%-1.05M | 69.98%-628.29K | -10.00%-1.69M | -126.72%-6.95M | 31.51%-1.58M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -12.03K | 100.03%5.75K | -55.75%330.08K | 104.25%25.23K | -77.57%301.98K | 0 | 143.71%2.88K | 148.77%745.96K | -227.22%-593.91K |
| Net PPE purchase and sale | --0 | ---- | ---- | 161.54%10.95K | 58,585.71%8.19K | 134.70%2.76K | --0 | --0 | 85.47%-17.79K | 99.86%-14 |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---275.78K | --0 | ---- | ---- | ---- | --0 | --0 |
| Net business purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --16.56K | --0 |
| Net investment purchase and sale | --0 | --0 | 100.03%5.75K | 201.12%594.91K | 102.96%17.04K | --575K | --0 | 121.59%2.88K | -820.46%-588.31K | -12,545.89%-575K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 199.42%1.34M | ---18.9K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---12.03K | 100.03%5.75K | -55.75%330.08K | 104.25%25.23K | -77.57%301.98K | --0 | 143.71%2.88K | 148.77%745.96K | -227.22%-593.91K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,701.01%37.05M | 419.69%81.13K | 125.09%176.18K | 54.79%10.84M | 21,712.06%9.81M | 754.12%974.66K | -25.38K | -98.90%78.27K | 5.29%7M | 166.65%44.99K |
| Net issuance payments of debt | --0 | --0 | --0 | 1,468.59%1.42M | 1,011.41%500K | 754.12%974.66K | ---25.38K | ---25.73K | 72.11%-104.02K | 166.65%44.99K |
| Net common stock issuance | ---- | ---- | ---- | 42.74%10.28M | --10.28M | --104K | --0 | --0 | 2.51%7.2M | --0 |
| Proceeds from stock option exercised by employees | --86.75K | --81.13K | 69.40%176.18K | ---- | ---- | --0 | --0 | --104K | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | -823.90%-860.83K | ---- | ---- | ---- | ---- | ---93.17K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3,701.01%37.05M | 419.69%81.13K | 125.09%176.18K | 54.79%10.84M | 21,712.06%9.81M | 754.12%974.66K | ---25.38K | -98.90%78.27K | 5.29%7M | 166.65%44.99K |
| Net cash flow | ||||||||||
| Beginning cash position | 900.18%5.98M | 541.86%8.03M | 226.23%9.34M | 39.05%2.86M | -83.40%822.68K | -89.12%597.98K | -83.57%1.25M | 39.05%2.86M | --2.06M | 12.06%4.96M |
| Current changes in cash | 14,768.23%33.41M | -214.06%-2.05M | 19.08%-1.3M | 705.52%6.47M | 499.43%8.51M | 142.00%224.7K | 68.76%-653.67K | -128.95%-1.61M | -60.95%803.81K | -11.52%-2.13M |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| End cash Position | 4,687.99%39.39M | 900.18%5.98M | 541.86%8.03M | 226.23%9.34M | 226.23%9.34M | -83.40%822.68K | -89.12%597.98K | -83.57%1.25M | 39.05%2.86M | 39.05%2.86M |
| Free cash from | -174.00%-3.64M | -239.66%-2.13M | 12.21%-1.49M | 28.61%-4.97M | 16.36%-1.32M | 23.71%-1.33M | 69.98%-628.29K | -9.30%-1.69M | -118.57%-6.96M | -213.24%-1.58M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.